ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
PEG화 단백질 시장 규모는 향후 몇 년 동안 급성장할 것으로 예상됩니다. 2029년에는 CAGR 12.9%로 27억 2,000만 달러로 성장할 것입니다. 예측 기간의 성장은 희귀질환에 대한 투자 증가, 바이오의약품 산업의 급성장, 정밀의료의 조정, 생물학적 제제의 바이오시밀러 버전과의 경쟁 심화, 혁신적인 시장진입 전략의 채택 등에 기인하는 것으로 보입니다. 예측 기간의 주요 동향으로는 디지털 헬스 기술 통합, 차세대 페지화 기술, 정밀 의료를 위한 맞춤형 제제, 병용요법에 대한 집중, 환자 중심 의료 모델로의 전환 등을 들 수 있습니다.
향후 5년간 12.9%의 성장률 전망은 지난번 예측보다 0.8% 소폭 하락한 수치입니다. 이 감소는 주로 미국과 다른 국가 간의 관세의 영향에 기인합니다. 관세 장벽은 스위스나 중국에서 조달하는 PEG화 시약 및 접합 생물학적 제제의 비용을 상승시키고, 신약의 처방을 지연시키거나 제조 비용을 상승시킴으로써 미국의 바이오의약품 부문을 저해할 것으로 예상됩니다. 또한, 상호 관세와 무역 마찰 및 제한 강화로 인한 세계 경제 및 무역에 대한 악영향으로 인해 그 영향은 더욱 광범위하게 나타날 것으로 보입니다.
생활습관병의 유병률 증가는 향후 몇 년 동안 PEG화 단백질 시장의 성장을 견인할 것으로 예상됩니다. 생활습관병은 주로 건강에 좋지 않은 식습관, 운동부족, 흡연 등 나쁜 습관이나 생활습관 선택으로 인해 발생하는 건강 상태를 말합니다. 이러한 질병은 신체 활동 감소, 가공식품 위주의 식습관, 스트레스 증가 등의 요인으로 인해 더욱 흔해지고 있습니다. PEG화 단백질은 심혈관질환, 당뇨병, 일부 암 등의 증상에 대한 치료제의 효능, 지속시간, 표적 전달을 개선하여 생활습관병 치료에 사용됩니다. 예를 들어, 2024년 5월 영국 정부 기관인 Office for Health Improvement and Disparities는 2022-2023년 영국 18세 이상 성인의 약 64.0%가 과체중 또는 비만으로 분류되어 2021-2022년의 63.8%보다 약간 증가했다고 보고했습니다. 소폭 증가했다고 보고했습니다. 그 결과, 생활습관병 유병률의 증가가 PEG화 단백질 시장의 성장에 기여하고 있습니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향과 전략
제4장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세, 그리고 코로나와 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
세계의 PEG화 단백질 : PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
최종 이용 산업 분석
세계의 PEG화 단백질 시장 : 성장률 분석
세계의 PEG화 단백질 시장 실적 : 규모와 성장, 2019-2024
세계의 PEG화 단백질 시장 예측 : 규모와 성장, 2024-2029, 2034F
세계의 PEG화 단백질 : 총 잠재 시장 규모(TAM)
제6장 시장 세분화
세계의 PEG화 단백질 시장 : 제품별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
소모품과 서비스
PEG화 키트 및 시약
단관능 직쇄 PEG
2 관능성 PEG
기타 제품
세계의 PEG화 단백질 시장 단백질 종류별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
집락자극인자
인터페론
에리스로포이에틴
재조합 인자 VII
기타 단백질 종류
세계의 PEG화 단백질 시장 : 용도별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
암 치료
간염
만성 신장병
혈우병
다발성 경화증
위장장애
기타 용도
세계의 PEG화 단백질 시장 : 최종사용자별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
의약품
바이오테크놀러지 기업
임상시험수탁기관
학술조사기관
세계의 PEG화 단백질 시장 : 하위 세분화 소모품과 서비스(종류별), 실적과 예측, 2019-2024, 2024-2029F, 2034F
소모품
서비스(계약 서비스, PEG화 서비스)
세계의 PEG화 단백질 시장 : 하위 세분화 PEG화 키트 및 시약(유형별), 실적과 예측, 2019-2024, 2024-2029F, 2034F
PEG화 키트
시약
세계의 PEG화 단백질 시장 : 하위 세분화 단관능 직쇄 PEG(유형별), 실적과 예측, 2019-2024, 2024-2029F, 2034F
단백질 변성을 위한 단관능 PEG
세계의 PEG화 단백질 시장 : 하위 세분화 2 관능성 PEG(유형별), 실적과 예측, 2019-2024, 2024-2029F, 2034F
단백질 변성을 위한 2 관능성 PEG
세계의 PEG화 단백질 시장 : 하위 세분화 기타 제품(유형별), 실적과 예측, 2019-2024, 2024-2029F, 2034F
공역
PEG화 의약품 및 치료제
제7장 지역별·국가별 분석
세계의 PEG화 단백질 시장 : 지역별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
세계의 PEG화 단백질 시장 : 국가별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 개요
PEG화 단백질 시장 : 경쟁 구도
PEG화 단백질 시장 : 기업 개요
Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
Bayer AG Overview, Products and Services, Strategy and Financial Analysis
Bristol Myers Squibb Company Overview, Products and Services, Strategy and Financial Analysis
AstraZeneca PLC Overview, Products and Services, Strategy and Financial Analysis
Roche Holding AG Overview, Products and Services, Strategy and Financial Analysis
제31장 기타 주요 기업과 혁신적 기업
Gilead Sciences Inc.
Novo Nordisk A/S
Evonik Industries AG
Viatris Inc.
Regeneron Pharmaceuticals Inc.
Biogen Inc.
Vertex Pharmaceuticals Incorporated
Lonza Group Ltd.
Jazz Pharmaceuticals plc
Ipsen Pharma
Kyowa Kirin Co. Ltd.
WuXi Biologics
BioMarin Pharmaceutical Inc.
Ligand Pharmaceuticals Incorporated
Zydus Cadila
제32장 세계의 시장 경쟁 벤치마킹과 대시보드
제33장 주요 인수합병
제34장 최근의 시장 동향
제35장 시장 잠재력이 높은 국가, 부문, 전략
PEG화 단백질 시장 2029 : 새로운 기회를 제공하는 국가
PEG화 단백질 시장 2029 : 새로운 기회를 제공하는 부문
PEG화 단백질 시장 2029 : 성장 전략
시장 동향에 기반한 전략
경쟁 전략
제36장 부록
KSM
영문 목차
영문목차
PEGylated proteins are therapeutic proteins covalently bonded to polyethylene glycol (PEG), a process aimed at enhancing their pharmacokinetic properties and reducing immunogenicity, thus improving their therapeutic efficacy. These modified proteins find application in various medical fields, including drug delivery, diagnostics, and targeted therapy, offering prolonged action and potentially improving patient outcomes.
The primary products within the PEGylated proteins market include consumables and services, pegylation kits and reagents, monofunctional linear PEGs, bifunctional PEGs, and others. Consumables and services constitute a broad category encompassing products and services vital for PEGylated protein research and development, including kits, reagents, and various support services. The proteins themselves cover a range of types such as colony-stimulating factors, interferons, erythropoietin, recombinant factor VII, and others, serving diverse applications including cancer treatment, hepatitis, chronic kidney diseases, hemophilia, multiple sclerosis, gastrointestinal disorders, and more. End users of these products and services include pharmaceutical companies, biotechnology firms, contract research organizations, and academic research institutes.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.
The PEGylated proteins market research report is one of a series of new reports from The Business Research Company that provides PEGylated proteins market statistics, including the PEGylated proteins industry global market size, regional shares, competitors with the PEGylated proteins market share, detailed PEGylated proteins market segments, market trends, and opportunities, and any further data you may need to thrive in the PEGylated proteins industry. These PEGylated proteins market research reports deliver a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The pegylated proteins market size has grown rapidly in recent years. It will grow from $1.47 billion in 2024 to $1.67 billion in 2025 at a compound annual growth rate (CAGR) of 13.8%. The growth in the historic period can be attributed to improved therapeutic efficacy, a growing aging population, demand for long-acting formulations, enhanced drug safety profiles, and expanding applications including targeted drug delivery systems.
The pegylated proteins market size is expected to see rapid growth in the next few years. It will grow to $2.72 billion in 2029 at a compound annual growth rate (CAGR) of 12.9%. The growth in the forecast period can be attributed to increasing investment in rare diseases, rapid growth of the biopharmaceutical industry, precision medicine tailoring, increasing competition from biosimilar versions of biologic drugs, and adoption of innovative market access strategies. Major trends in the forecast period include the integration of digital health technologies, next-generation pegylation technologies, customized formulations for precision medicine, a focus on combination therapies, and a shift towards patient-centric healthcare models.
The forecast of 12.9% growth over the next five years reflects a modest reduction of 0.8% from the previous estimate for this market. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff barriers are expected to hamper the U.S. biopharma sector by increasing the cost of PEGylation reagents and conjugated biologic drugs sourced from Switzerland and China, thereby delaying novel drug formulations and elevating manufacturing costs. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.
The growing prevalence of lifestyle diseases is expected to drive the growth of the PEGylated proteins market in the coming years. Lifestyle diseases are health conditions primarily caused by poor habits and lifestyle choices, such as an unhealthy diet, lack of physical activity, and smoking. These diseases are becoming more common due to factors like reduced physical activity, diets rich in processed foods, and heightened stress levels. PEGylated proteins are used in the treatment of lifestyle diseases by improving the effectiveness, duration, and targeted delivery of therapeutic agents for conditions like cardiovascular diseases, diabetes, and some cancers. For example, in May 2024, the Office for Health Improvement and Disparities, a UK-based government agency, reported that in 2022-2023, approximately 64.0% of adults aged 18 and over in England were classified as overweight or obese, a slight increase from 63.8% in 2021-2022. As a result, the rising prevalence of lifestyle diseases is contributing to the growth of the PEGylated proteins market.
Key players in the PEGylated proteins market are focusing on the development of innovative products such as PEGylation reagents to maintain a competitive edge. PEGylation reagents are chemical compounds that attach polyethylene glycol (PEG) chains to biomolecules, modifying their properties for various biomedical applications. For instance, Creative Enzymes, a US-based supplier of food additives and enzymes, introduced DSPE-PEG-Maleimide in May 2023 for targeted drug delivery. DSPE-PEG-Maleimide is a linear heterobifunctional PEGylation reagent containing DSPE phospholipids and maleimide, serving as a valuable self-assembly reagent for preparing PEGylated liposomes or micelles and providing thiol or cysteine reactive maleimide groups, commonly used in targeted drug delivery.
In February 2022, Merck KGaA, a pharmaceutical company based in Germany, acquired Exelead Inc. for $793 million to bolster its presence in the growing market for mRNA therapeutics. Exelead Inc., a US-based biopharmaceutical company specializing in GMP-certified PEGylation services for use in manufacturing process development, is expected to enhance Merck KGaA's capabilities in this sector.
Major companies operating in the PEGylated proteins market are Merck & Co. Inc., Bayer AG, Bristol Myers Squibb Company, AstraZeneca PLC, Roche Holding AG, Gilead Sciences Inc., Novo Nordisk A/S, Evonik Industries AG, Viatris Inc., Regeneron Pharmaceuticals Inc., Biogen Inc., Vertex Pharmaceuticals Incorporated, Lonza Group Ltd., Jazz Pharmaceuticals plc, Ipsen Pharma, Kyowa Kirin Co. Ltd., WuXi Biologics, BioMarin Pharmaceutical Inc., Ligand Pharmaceuticals Incorporated, Zydus Cadila, Enzon Pharmaceuticals Inc.
North America was the largest region in the PEGylated Proteins market in 2024. The regions covered in the PEGylated proteins market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the PEGylated proteins market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The PEGylated proteins market consists of revenues earned by entities by providing services such as analytical services and contract manufacturing services for PEGylated protein. The market value includes the value of related goods sold by the service provider or included within the service offering. The PEGylated proteins market also includes sales of PEGylated enzymes, PEGylated antibodies, and PEGylated hormones. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
PEGylated Proteins Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on pegylated proteins market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for pegylated proteins ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The pegylated proteins market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:1) By Product: Consumable And Services; PEGylation Kits And Reagents; Monofunctional Linear PEGs; Bifunctional PEGs; Services; Other Products
2) By Protein Type: Colony Stimulating Factors; Interferons; Erythropoietin; Recombinant Factor VII; Other Protein Types
3) By Application: Cancer Treatment; Hepatitis; Chronic Kidney Diseases; Hemophilia; Multiple Sclerosis; Gastrointestinal Disorders; Other Applications
4) By End User: Pharmaceuticals; Biotechnology Companies; Contract Research Organizations; Academic Research Institutes
Subsegments:
1) By Consumable And Services: Consumables; Services (Contract Services, PEGylation Services)
2) By PEGylation Kits And Reagents: PEGylation Kits; Reagents
3) By Monofunctional Linear PEGs: Monofunctional PEGs For Protein Modification
4) By Bifunctional PEGs: Bifunctional PEGs For Protein Modification
5) By Other Products: Conjugates; PEGylated Drugs And Therapeutics
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. PEGylated Proteins Market Characteristics
3. PEGylated Proteins Market Trends And Strategies
4. PEGylated Proteins Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
4.1. Supply Chain Impact from Tariff War & Trade Protectionism
5. Global PEGylated Proteins Growth Analysis And Strategic Analysis Framework
5.1. Global PEGylated Proteins PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global PEGylated Proteins Market Growth Rate Analysis
5.4. Global PEGylated Proteins Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global PEGylated Proteins Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global PEGylated Proteins Total Addressable Market (TAM)
6. PEGylated Proteins Market Segmentation
6.1. Global PEGylated Proteins Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Consumable And Services
PEGylation Kits And Reagents
Monofunctional Linear PEGs
Bifunctional PEGs
Other Products
6.2. Global PEGylated Proteins Market, Segmentation By Protein Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Colony Stimulating Factors
Interferons
Erythropoietin
Recombinant Factor VII
Other Protein Types
6.3. Global PEGylated Proteins Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Cancer Treatment
Hepatitis
Chronic Kidney Diseases
Hemophilia
Multiple Sclerosis
Gastrointestinal Disorders
Other Applications
6.4. Global PEGylated Proteins Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Pharmaceuticals
Biotechnology Companies
Contract Research Organizations
Academic Research Institutes
6.5. Global PEGylated Proteins Market, Sub-Segmentation Of Consumable And Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Consumables
Services (Contract Services, PEGylation Services)
6.6. Global PEGylated Proteins Market, Sub-Segmentation Of PEGylation Kits And Reagents, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
PEGylation Kits
Reagents
6.7. Global PEGylated Proteins Market, Sub-Segmentation Of Monofunctional Linear PEGs, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Monofunctional PEGs For Protein Modification
6.8. Global PEGylated Proteins Market, Sub-Segmentation Of Bifunctional PEGs, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Bifunctional PEGs For Protein Modification
6.9. Global PEGylated Proteins Market, Sub-Segmentation Of Other Products, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Conjugates
PEGylated Drugs And Therapeutics
7. PEGylated Proteins Market Regional And Country Analysis
7.1. Global PEGylated Proteins Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global PEGylated Proteins Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion